1887

Chapter 15 : Molecular Detection of Colonization and Infection

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Molecular Detection of Colonization and Infection, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819071/9781555819088.ch15-1.gif /docserver/preview/fulltext/10.1128/9781555819071/9781555819088.ch15-2.gif

Abstract:

Prevention and control of infection with , including methicillin-resistant (MRSA), have been a major health care focus since at least the middle of the 20th century (1). By 2005, mortality from MRSA in the United States exceeded that due to infections from salmonella, tuberculosis, influenza, and HIV combined (2, 3). Since that time, global efforts to reduce MRSA infection rates appear to have had some impact in both Europe and the United States (4–6). However, the improvement has not been uniform, with selected academic medical centers not realizing a reduction in disease (7), and at least one large state (Illinois) reporting an increase in overall MRSA infection reflected in their most recent data, with 11.7 MRSA infections/1,000 hospital discharges in 2009, 11.6 in 2010, 10.7 in 2011, and then up to 14.2 in 2012 (8).

Citation: Mangold K, Peterson L. 2016. Molecular Detection of Colonization and Infection, p 169-184. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch15
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555819071.ch15
1. Wise RI, Ossman EA, Littlefield DR. 1989. Personal reflections on nosocomial staphylococcal infections and the development of hospital surveillance. Rev Infect Dis 11:10051019[CrossRef].[PubMed]
2. DeLeo FR, Chambers HF. 2009. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest 119:24642474[CrossRef].[PubMed]
3. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK, Active Bacterial Core surveillance (ABCs) MRSA Investigators. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:17631771[CrossRef].[PubMed]
4. Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, Duckworth G. 2012. Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother 67:802809[CrossRef].[PubMed]
5. de Kraker ME, Jarlier V, Monen JC, Heuer OE, van de Sande N, Grundmann H. 2013. The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microbiol Infect 19:860868[CrossRef].[PubMed]
6. Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S,, Emerging Infections Program–Active Bacterial Core Surveillance MRSA Surveillance Investigators. 2013. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 173:19701978.[PubMed]
7. David MZ, Daum RS, Bayer AS, Chambers HF, Fowler VG Jr, Miller LG, Ostrowsky B, Baesa A, Boyle-Vavra S, Eells SJ, Garcia-Houchins S, Gialanella P, Macias-Gil R, Rude TH, Ruffin F, Sieth JJ, Volinski J, Spellberg B. 2014. Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008–2011: significant geographic variation in community-onset infections. Clin Infect Dis 59:798807[CrossRef].[PubMed]
8. Terp S, Krishnadasan A, Bowen W, Joo J, Furoy D, Chan J, Moran G, Talan D. 2014. Introduction of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing and antibiotic selection among hospitalized patients with purulent skin infections. Clin Infect Dis 58:e129e132[CrossRef].[PubMed]
9. Selkon JB, Stokes ER, Ingham HR. 1980. The role of an isolation unit in the control of hospital infection with methicillin-resistant staphylococci. J Hosp Infect 1:4146[CrossRef].[PubMed]
10. Peterson LR, Diekema DJ. 2010. To screen or not to screen for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 48:683689[CrossRef].[PubMed]
11. Kavanagh KT, Saman DM, Yu Y. 2013. A perspective on how the United States fell behind Northern Europe in the battle against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 57:57895791[CrossRef].[PubMed]
12. Ridgway JP, Peterson LR, Brown EC, Du H, Hebert C, Thomson RB Jr, Kaul KL, Robicsek A. 2013. Clinical significance of methicillin-resistant Staphylococcus aureus colonization on hospital admission: one-year infection risk. PLoS One 8:e79716[CrossRef].[PubMed]
13. Chang S, Sethi AK, Eckstein BC, Stiefel U, Cadnum JL, Donskey CJ. 2009. Skin and environmental contamination with methicillin-resistant Staphylococcus aureus among carriers identified clinically versus through active surveillance. Clin Infect Dis 48:14231428[CrossRef].[PubMed]
14. Milstone AM, Goldner BW, Ross T, Shepard JW, Carroll KC, Perl TM. 2011. Methicillin-resistant Staphylococcus aureus colonization and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant Staphylococcus aureus transmission. Clin Infect Dis 53:853859[CrossRef].[PubMed]
15. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK, Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. 2014. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370:11981208[CrossRef].[PubMed]
16. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. 2005. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26:166174[CrossRef].[PubMed]
17. Hanberger H, Walther S, Leone M, Barie PS, Rello J, Lipman J, Marshall JC, Anzueto A, Sakr Y, Pickkers P, Felleiter P, Engoren M, Vincent JL, EPIC II Group of Investigators. 2011. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int J Antimicrob Agents 38:331335[CrossRef].[PubMed]
18. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. 2003. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:5359[CrossRef].[PubMed]
19. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS. 2003. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 36:592598[CrossRef].[PubMed]
20. Peterson LR, Hacek DM, Robicsek A. 2007. 5 million lives campaign. Case study: an MRSA intervention at Evanston Northwestern Health Care. Jt Comm J Qual Patient Saf 33:732738.[PubMed]
21. Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, Keohane C, Denham CR, Bates DW. 2013. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 173:20392046[CrossRef].[PubMed]
22. French GL. 2009. Methods for screening for methicillin-resistant Staphylococcus aureus carriage. Clin Microbiol Infect 15(Suppl 7):1016[CrossRef].[PubMed]
23. Harbarth S, Hawkey PM, Tenover F, Stefani S, Pantosti A, Struelens MJ. 2011. Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 37:110117[CrossRef].[PubMed]
24. Kunori T, Cookson B, Roberts JA, Stone S, Kibbler C. 2002. Cost-effectiveness of different MRSA screening methods. J Hosp Infect 51:189200[CrossRef].[PubMed]
25. Robicsek A, Beaumont JL, Paule SM, Hacek DM, Thomson RB Jr, Kaul KL, King P, Peterson LR. 2008. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 148:409418[CrossRef].[PubMed]
26. Jain R, Kralovic SM, Evans ME, Ambrose M, Simbartl LA, Obrosky DS, Render ML, Freyberg RW, Jernigan JA, Muder RR, Miller LJ, Roselle GA. 2011. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 364:14191430[CrossRef].[PubMed]
27. Evans ME, Kralovic SM, Simbartl LA, Freyberg RW, Obrosky DS, Roselle GA, Jain R. 2013. Veterans Affairs methicillin-resistant Staphylococcus aureus prevention initiative associated with a sustained reduction in transmissions and health care-associated infections. Am J Infect Control 41:10931095[CrossRef].[PubMed]
28. Jones M, Ying J, Huttner B, Evans M, Maw M, Nielson C, Rubin MA, Greene T, Samore MH. 2014. Relationships between the importation, transmission, and nosocomial infections of methicillin-resistant Staphylococcus aureus: an observational study of 112 Veterans Affairs Medical Centers. Clin Infect Dis 58:3239[CrossRef].[PubMed]
29. Paule SM, Mehta M, Hacek DM, Gonzalzles TM, Robicsek A, Peterson LR. 2009. Chromogenic media vs real-time PCR for nasal surveillance of methicillin-resistant Staphylococcus aureus: impact on detection of MRSA-positive persons. Am J Clin Pathol 131:532539[CrossRef].[PubMed]
30. Patel PA, Robicsek A, Grayes A, Schora DM, Peterson KE, Wright MO, Peterson LR. 2015. Evaluation of multiple real-time PCR tests on nasal samples in a large MRSA surveillance program. Am J Clin Pathol 143:652658[CrossRef].[PubMed]
31. Centers for Disease Control and Prevention. 2014. Hospital utilization (in non-federal short-stay hospitals). http://www.cdc.gov/nchs/fastats/hospital.htm.
32. Tacconelli E, De Angelis G, de Waure C, Cataldo MA, La Torre G, Cauda R. 2009. Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis 9:546554[CrossRef].[PubMed]
33. Glick SB, Samson DJ, Huang ES, Vats V, Aronson N, Weber SG. 2014. Screening for methicillin-resistant Staphylococcus aureus: a comparative effectiveness review. Am J Infect Control 42:148155[CrossRef].[PubMed]
34. McKinnell JA, Miller LG, Eells SJ, Cui E, Huang SS. 2013. A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol 34:10771086[CrossRef].[PubMed]
35. Robicsek A, Beaumont JL, Wright MO, Thomson RB Jr, Kaul KL, Peterson LR. 2011. Electronic prediction rules for methicillin-resistant Staphylococcus aureus colonization. Infect Control Hosp Epidemiol 32:919[CrossRef].[PubMed]
36. Levy PY, Ollivier M, Drancourt M, Raoult D, Argenson JN. 2013. Relation between nasal carriage of Staphylococcus aureus and surgical site infection in orthopedic surgery: the role of nasal contamination. A systematic literature review and meta-analysis. Orthop Traumatol Surg Res 99:645651[CrossRef].[PubMed]
37. Hacek DM, Robb WJ, Paule SM, Kudrna JC, Stamos VP, Peterson LR. 2008. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res 466:13491355[CrossRef].[PubMed]
38. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, Troelstra A, Box AT, Voss A, van der Tweel I, van Belkum A, Verbrugh HA, Vos MC. 2010. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 362:917[CrossRef].[PubMed]
39. Mehta MS, Hacek DM, Kufner BA, Price C, Peterson LR. 2013. Dose-ranging study to assess the application of intranasal 2% mupirocin calcium ointment to eradicate Staphylococcus aureus nasal colonization. Surg Infect (Larchmt) 14:6972[CrossRef].[PubMed]
40. Lee AS, Cooper BS, Malhotra-Kumar S, Chalfine A, Daikos GL, Fankhauser C, Carevic B, Lemmen S, Martínez JA, Masuet-Aumatell C, Pan A, Phillips G, Rubinovitch B, Goossens H, Brun-Buisson C, Harbarth S, MOSAR WP4 Study Group. 2013. Comparison of strategies to reduce meticillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trial. BMJ Open 3:e003126[CrossRef].[PubMed]
41. Courville XF, Tomek IM, Kirkland KB, Birhle M, Kantor SR, Finlayson SR. 2012. Cost-effectiveness of preoperative nasal mupirocin treatment in preventing surgical site infection in patients undergoing total hip and knee arthroplasty: a cost-effectiveness analysis. Infect Control Hosp Epidemiol 33:152159[CrossRef].[PubMed]
42. Brown DFJ, Edwards DI, Hawkey PM, Morrison D, Ridgway GL, Towner KJ, Wren MW, Joint Working Party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society, Infection Control Nurses Association. 2005. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother 56:10001018[CrossRef].[PubMed]
43. Marlowe EM, Bankowski MJ. 2011. Conventional and molecular methods for the detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 49(9 Supplement):S53S56[CrossRef].
44. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y, Lian J, Ito T, Kanamori M, Matsumaru H, Maruyama A, Murakami H, Hosoyama A, Mizutani-Ui Y, Takahashi NK, Sawano T, Inoue R, Kaito C, Sekimizu K, Hirakawa H, Kuhara S, Goto S, Yabuzaki J, Kanehisa M, Yamashita A, Oshima K, Furuya K, Yoshino C, Shiba T, Hattori M, Ogasawara N, Hayashi H, Hiramatsu K. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357:12251240[CrossRef].[PubMed]
45. Ito T, Kuwahara-Arai K, Katayama Y, Uehara Y, Han X, Kondo Y, Hiramatsu K. 2014. Staphylococcal cassette chromosome mec (SCCmec) analysis of MRSA. Methods Mol Biol 1085:131148[CrossRef].[PubMed]
46. Huletsky A, Giroux R, Rossbach V, Gagnon M, Vaillancourt M, Bernier M, Gagnon F, Truchon K, Bastien M, Picard FJ, van Belkum A, Ouellette M, Roy PH, Bergeron MG. 2004. New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J Clin Microbiol 42:18751884[CrossRef].[PubMed]
47. Stürenburg E. 2009. Rapid detection of methicillin-resistant Staphylococcus aureus directly from clinical samples: methods, effectiveness and cost considerations. Ger Med Sci 7:Doc06.[PubMed]
48. Davis TE, Fuller DD. 1991. Direct identification of bacterial isolates in blood cultures by using a DNA probe. J Clin Microbiol 29:21932196.[PubMed]
49. Paule SM, Pasquariello AC, Hacek DM, Fisher AG, Thomson RB Jr, Kaul KL, Peterson LR. 2004. Direct detection of Staphylococcus aureus from adult and neonate nasal swab specimens using real-time polymerase chain reaction. J Mol Diagn 6:191196[CrossRef].[PubMed]
50. Sundsfjord A, Simonsen GS, Haldorsen BC, Haaheim H, Hjelmevoll SO, Littauer P, Dahl KH. 2004. Genetic methods for detection of antimicrobial resistance. APMIS 112:815837[CrossRef].[PubMed]
51. Paule SM, Pasquariello AC, Thomson RB Jr, Kaul KL, Peterson LR. 2005. Real-time PCR can rapidly detect methicillin-susceptible and methicillin-resistant Staphylococcus aureus directly from positive blood culture bottles. Am J Clin Pathol 124:404407[CrossRef].[PubMed]
52. Francois P, Pittet D, Bento M, Pepey B, Vaudaux P, Lew D, Schrenzel J. 2003. Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay. J Clin Microbiol 41:254260[CrossRef].[PubMed]
53. Paule SM, Hacek DM, Kufner B, Truchon K, Thomson RB Jr, Kaul KL, Robicsek A, Peterson LR. 2007. Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high-volume clinical use. J Clin Microbiol 45:29932998[CrossRef].[PubMed]
54. Forrest GN. 2007. PNA FISH: present and future impact on patient management. Expert Rev Mol Diagn 7:231236[CrossRef].[PubMed]
55. Parcell BJ, Orange GV. 2013. PNA-FISH assays for early targeted bacteraemia treatment. J Microbiol Methods 95:253255[CrossRef].[PubMed]
56. Calderaro A, Martinelli M, Motta F, Larini S, Arcangeletti MC, Medici MC, Chezzi C, De Conto F. 2014. Comparison of peptide nucleic acid fluorescence in situ hybridization assays with culture-based matrix-assisted laser desorption/ionization-time of flight mass spectrometry for the identification of bacteria and yeasts from blood cultures and cerebrospinal fluid cultures. Clin Microbiol Infect 20:O468O475[CrossRef].[PubMed]
57. Martinez RM, Bauerle ER, Fang FC, Butler-Wu SM. 2014. Evaluation of three rapid diagnostic methods for direct identification of microorganisms in positive blood cultures. J Clin Microbiol 52:25212529[CrossRef].[PubMed]
58. Morgan MA. 2013. Ten years of experience with peptide nucleic acid fluorescent in situ hybridization in the clinical microbiology laboratory. Clin Microbiol Newsl 35:7983[CrossRef].
59. Leitner E, Scherr S, Strempfl C, Krause R, Feierl G, Grisold AJ. 2013. Rapid identification of pathogens with the hemoFISH test applying a novel beacon-based fluorescence in situ hybridization (bbFISH) technology in positive blood culture bottles. J Mol Diagn 15:835839[CrossRef].[PubMed]
60. Sakarikou C, Parisato M, Lo Cascio G, Fontana C. 2014. Beacon-based (bbFISH®) technology for rapid pathogens identification in blood cultures. BMC Microbiol 14:99[CrossRef].[PubMed]
61. Shore AC, Coleman DC. 2013. Staphylococcal cassette chromosome mec: recent advances and new insights. Int J Med Microbiol 303:350359[CrossRef].[PubMed]
62. Paterson GK, Harrison EM, Holmes MA. 2014. The emergence of mecC methicillin-resistant Staphylococcus aureus. Trends Microbiol 22:4247[CrossRef].[PubMed]
63. Shore AC, Deasy EC, Slickers P, Brennan G, O'Connell B, Monecke S, Ehricht R, Coleman DC. 2011. Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 55:37653773[CrossRef].[PubMed]
64. Becker K, Ballhausen B, Köck R, Kriegeskorte A. 2014. Methicillin resistance in Staphylococcus isolates: the “mec alphabet” with specific consideration of mecC, a mec homolog associated with zoonotic S. aureus lineages. Int J Med Microbiol 304:794804[CrossRef].[PubMed]
65. Petersen A, Stegger M, Heltberg O, Christensen J, Zeuthen A, Knudsen LK, Urth T, Sorum M, Schouls L, Larsen J, Skov R, Larsen AR. 2013. Epidemiology of methicillin-resistant Staphylococcus aureus carrying the novel mecC gene in Denmark corroborates a zoonotic reservoir with transmission to humans. Clin Microbiol Infect 19:E16E22[CrossRef].[PubMed]
66. Warren DK, Liao RS, Merz LR, Eveland M, Dunne WM Jr. 2004. Detection of methicillin-resistant Staphylococcus aureus directly from nasal swab specimens by a real-time PCR assay. J Clin Microbiol 42:55785581[CrossRef].[PubMed]
67. Donnio PY, Oliveira DC, Faria NA, Wilhelm N, Le Coustumier A, de Lencastre H. 2005. Partial excision of the chromosomal cassette containing the methicillin resistance determinant results in methicillin-susceptible Staphylococcus aureus. J Clin Microbiol 43:41914193[CrossRef].[PubMed]
68. Patel PA, Ledeboer NA, Ginocchio CC, Condon S, Bouchard S, Qin P, Karchmer T, Peterson LR. 2011. Performance of the BD GeneOhm MRSA achromopeptidase assay for real-time PCR detection of methicillin-resistant Staphylococcus aureus in nasal specimens. J Clin Microbiol 49:22662268[CrossRef].[PubMed]
69. Widen R, Healer V, Silbert S. 2014. Laboratory evaluation of the BD MAX MRSA assay. J Clin Microbiol 52:26862688[CrossRef].[PubMed]
70. Ledeboer NA, Reymann GC, Riebe KM, Connolly J, Buchan BW. 2014. Comparison of the BD MAX™ StaphSR and Cepheid® Xpert® SA Nasal Complete Molecular Assays for the detection of S. aureus and methicillin-resistant S. aureus (MRSA) in nasal swab specimens, asm2014 C-2550. In (ed),
71. Arcenas RC, Spadoni S, Mohammad A, Kiechle FL, Walker K, Fader RC, Perdreau-Remington F, Osiecki J, Liesenfeld O, Hendrickson S, Rao A. 2012. Multicenter evaluation of the LightCycler MRSA advanced test, the Xpert MRSA Assay, and MRSASelect directly plated culture with simulated workflow comparison for the detection of methicillin-resistant Staphylococcus aureus in nasal swabs. J Mol Diagn 14:367375[CrossRef].[PubMed]
72. Aydiner A, Lüsebrink J, Schildgen V, Winterfeld I, Knüver O, Schwarz K, Messler S, Schildgen O, Mattner F. 2012. Comparison of two commercial PCR methods for methicillin-resistant Staphylococcus aureus (MRSA) screening in a tertiary care hospital. PLoS One 7:e43935[CrossRef].[PubMed]
73. Belmekki M, Mammeri H, Hamdad F, Rousseau F, Canarelli B, Biendo M. 2013. Comparison of Xpert MRSA/SA Nasal and MRSA/SA ELITe MGB assays for detection of the mecA gene with susceptibility testing methods for determination of methicillin resistance in Staphylococcus aureus isolates. J Clin Microbiol 51:31833191[CrossRef].[PubMed]
74. Rossney AS, Herra CM, Brennan GI, Morgan PM, O'Connell B. 2008. Evaluation of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay using the GeneXpert real-time PCR platform for rapid detection of MRSA from screening specimens. J Clin Microbiol 46:32853290[CrossRef].[PubMed]
75. Andersen BM, Tollefsen T, Seljordslia B, Hochlin K, Syversen G, Jonassen TO, Rasch M, Sandvik L. 2010. Rapid MRSA test in exposed persons: costs and savings in hospitals. J Infect 60:293299[CrossRef].[PubMed]
76. Nulens E, Descheemaeker P, Deurenberg RH, Stobberingh EE, Gordts B. 2010. Contribution of two molecular assays as compared to selective culture for MRSA screening in a low MRSA prevalence population. Infection 38:98101[CrossRef].[PubMed]
77. Blanc DS, Nahimana I, Zanetti G, Greub G. 2013. MRSA screening by the Xpert MRSA PCR assay: pooling samples of the nose, throat, and groin increases the sensitivity of detection without increasing the laboratory costs. Eur J Clin Microbiol Infect Dis 32:565568[CrossRef].[PubMed]
78. Eigner U, Veldenzer A, Betz U, Bertsch D, Holfelder M. 2013. Evaluation of the new HyBeacon-based PCR assay, FluoroType MRSA, for the direct detection of MRSA in clinical specimens, 23rd ECCMID P-1896.
79. Sherlock O, Dolan A, Humphreys H. 2010. MRSA screening: can one swab be used for both culture and rapid testing? An evaluation of chromogenic culture and subsequent Hain GenoQuick PCR amplification/detection. Clin Microbiol Infect 16:955959[CrossRef].[PubMed]
80. Holfelder M, Eigner U, Turnwald AM, Witte W, Weizenegger M, Fahr A. 2006. Direct detection of methicillin-resistant Staphylococcus aureus in clinical specimens by a nucleic acid-based hybridisation assay. Clin Microbiol Infect 12:11631167[CrossRef].[PubMed]
81. Wagenvoort JH, van de Cruijs MF, Meuwissen CT, Gronenschild JM, De Brauwer EI. 2007. Comparison of an enrichment broth-enhanced commercial PCR procedure versus bacteriological culture for separating non-colonized from suspected or colonized MRSA individuals. Eur J Clin Microbiol Infect Dis 26:155160[CrossRef].[PubMed]
82. Dubouix-Bourandy A, de Ladoucette A, Pietri V, Mehdi N, Benzaquen D, Guinand R, Gandois JM. 2011. Direct detection of Staphylococcus osteoarticular infections by use of Xpert MRSA/SA SSTI real-time PCR. J Clin Microbiol 49:42254230[CrossRef].[PubMed]
83. Cercenado E, Marín M, Burillo A, Martín-Rabadán P, Rivera M, Bouza E. 2012. Rapid detection of Staphylococcus aureus in lower respiratory tract secretions from patients with suspected ventilator-associated pneumonia: evaluation of the Cepheid Xpert MRSA/SA SSTI assay. J Clin Microbiol 50:40954097[CrossRef].[PubMed]
84. Metso L, Mäki M, Tissari P, Remes V, Piiparinen P, Kirveskari J, Tarkka E, Anttila VJ, Vaara M, Huotari K. 2014. Efficacy of a novel PCR- and microarray-based method in diagnosis of a prosthetic joint infection. Acta Orthop 85:165170[CrossRef].[PubMed]
85. Stamper PD, Cai M, Howard T, Speser S, Carroll KC. 2007. Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures. J Clin Microbiol 45:21912196[CrossRef].[PubMed]
86. Blaschke AJ, Heyrend C, Byington CL, Fisher MA, Barker E, Garrone NF, Thatcher SA, Pavia AT, Barney T, Alger GD, Daly JA, Ririe KM, Ota I, Poritz MA. 2012. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis 74:349355[CrossRef].[PubMed]
87. Bhatti MM, Boonlayangoor S, Beavis KG, Tesic V. 2014. Evaluation of FilmArray and Verigene systems for rapid identification of positive blood cultures. J Clin Microbiol 52:34333436[CrossRef].[PubMed]
88. Baldwin CD, Howe GB, Sampath R, Blyn LB, Matthews H, Harpin V, Hall TA, Drader JJ, Hofstadler SA, Eshoo MW, Rudnick K, Studarus K, Moore D, Abbott S, Janda JM, Whitehouse CA. 2009. Usefulness of multilocus polymerase chain reaction followed by electrospray ionization mass spectrometry to identify a diverse panel of bacterial isolates. Diagn Microbiol Infect Dis 63:403408[CrossRef].[PubMed]
89. Wolk DM, Blyn LB, Hall TA, Sampath R, Ranken R, Ivy C, Melton R, Matthews H, White N, Li F, Harpin V, Ecker DJ, Limbago B, McDougal LK, Wysocki VH, Cai M, Carroll KC. 2009. Pathogen profiling: rapid molecular characterization of Staphylococcus aureus by PCR/electrospray ionization-mass spectrometry and correlation with phenotype. J Clin Microbiol 47:31293137[CrossRef].[PubMed]
90. Tissari P, Zumla A, Tarkka E, Mero S, Savolainen L, Vaara M, Aittakorpi A, Laakso S, Lindfors M, Piiparinen H, Mäki M, Carder C, Huggett J, Gant V. 2010. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet 375:224230[CrossRef].[PubMed]
91. Afshari A, Schrenzel J, Ieven M, Harbarth S. 2012. Bench-to-bedside review: rapid molecular diagnostics for bloodstream infection—a new frontier? Crit Care 16:222[CrossRef].[PubMed]
92. Youmans GR, Davis TE, Fuller DD. 1993. Use of chemiluminescent DNA probes in the rapid detection of oxacillin resistance in clinically isolated strains of Staphylococcus aureus. Diagn Microbiol Infect Dis 16:99104[CrossRef].[PubMed]
93. Skulnick M, Simor AE, Patel MP, Simpson HE, O'Quinn KJ, Low DE, Phillips AM, Small GW. 1994. Evaluation of three methods for the rapid identification of Staphylococcus aureus in blood cultures. Diagn Microbiol Infect Dis 19:58[CrossRef].[PubMed]
94. Lindholm L, Sarkkinen H. 2004. Direct identification of gram-positive cocci from routine blood cultures by using AccuProbe tests. J Clin Microbiol 42:56095613[CrossRef].[PubMed]
95. Otte KM, Jenner S, Wulffen HV. 2005. Identification of methicillin-resistant Staphylococcus aureus (MRSA): comparison of a new molecular genetic test kit (GenoType MRSA) with standard diagnostic methods. Clin Lab 51:389393.[PubMed]
96. Eigner U, Weizenegger M, Fahr AM, Witte W. 2005. Evaluation of a rapid direct assay for identification of bacteria and the mec A and van genes from positive-testing blood cultures. J Clin Microbiol 43:52565262[CrossRef].[PubMed]
97. Moon HW, Lee SH, Chung HS, Lee M, Lee K. 2013. Performance of the Vitek MS matrix-assisted laser desorption ionization time-of-flight mass spectrometry system for identification of Gram-positive cocci routinely isolated in clinical microbiology laboratories. J Med Microbiol 62:13011306[CrossRef].[PubMed]
98. Leitner E, Kessler HH, Spindelboeck W, Hoenigl M, Putz-Bankuti C, Stadlbauer-Köllner V, Krause R, Grisold AJ, Feierl G, Stauber RE. 2013. Comparison of two molecular assays with conventional blood culture for diagnosis of sepsis. J Microbiol Methods 92:253255[CrossRef].[PubMed]
99. Schreiber J, Nierhaus A, Braune SA, de Heer G, Kluge S. 2013. Comparison of three different commercial PCR assays for the detection of pathogens in critically ill sepsis patients. Med Klin Intensivmed Notf Med 108:311318[CrossRef].[PubMed]
100. Carrara L, Navarro F, Turbau M, Seres M, Morán I, Quintana I, Martino R, González Y, Brell A, Cordon O, Diestra K, Mata C, Mirelis B, Coll P. 2013. Molecular diagnosis of bloodstream infections with a new dual-priming oligonucleotide-based multiplex PCR assay. J Med Microbiol 62:16731679[CrossRef].[PubMed]
101. Loonen AJ, de Jager CP, Tosserams J, Kusters R, Hilbink M, Wever PC, van den Brule AJ. 2014. Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit. PLoS One 9:e87315[CrossRef].[PubMed]
102. Snyder JW, Munier GK, Heckman SA, Camp P, Overman TL. 2009. Failure of the BD GeneOhm StaphSR assay for direct detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates in positive blood cultures collected in the United States. J Clin Microbiol 47:37473748[CrossRef].[PubMed]
103. Thomas L, van Hal S, O'Sullivan M, Kyme P, Iredell J. 2008. Failure of the BD GeneOhm StaphS/R assay for identification of Australian methicillin-resistant Staphylococcus aureus strains: duplex assays as the “gold standard” in settings of unknown SCCmec epidemiology. J Clin Microbiol 46:41164117[CrossRef].[PubMed]
104. Altun O, Almuhayawi M, Ullberg M, Ozenci V. 2013. Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. J Clin Microbiol 51:41304136[CrossRef].[PubMed]
105. Arbefeville SS, Zhang K, Kroeger JS, Howard WJ, Diekema DJ, Richter SS. 2011. Prevalence and genetic relatedness of methicillin-susceptible Staphylococcus aureus isolates detected by the Xpert MRSA nasal assay. J Clin Microbiol 49:29962999[CrossRef].[PubMed]
106. Roisin S, Laurent C, Nonhoff C, Deplano A, Hallin M, Byl B, Struelens MJ, Denis O. 2012. Positive predictive value of the Xpert MRSA assay diagnostic for universal patient screening at hospital admission: influence of the local ecology. Eur J Clin Microbiol Infect Dis 31:873880[CrossRef].[PubMed]
107. Shore AC, Rossney AS, O'Connell B, Herra CM, Sullivan DJ, Humphreys H, Coleman DC. 2008. Detection of staphylococcal cassette chromosome mec-associated DNA segments in multiresistant methicillin-susceptible Staphylococcus aureus (MSSA) and identification of Staphylococcus epidermidis ccrAB4 in both methicillin-resistant S. aureus and MSSA. Antimicrob Agents Chemother 52:44074419[CrossRef].[PubMed]
108. Stojanov M, Blanc DS. 2014. Characterization of the staphylococcal cassette chromosome mec insertion site in 108 isolates lacking the mecA gene and identified as methicillin-resistant Staphylococcus aureus by the Xpert MRSA assay. Eur J Clin Microbiol Infect Dis 33:19671971[CrossRef].[PubMed]
109. Laurent C, Bogaerts P, Schoevaerdts D, Denis O, Deplano A, Swine C, Struelens MJ, Glupczynski Y. 2010. Evaluation of the Xpert MRSA assay for rapid detection of methicillin-resistant Staphylococcus aureus from nares swabs of geriatric hospitalized patients and failure to detect a specific SCCmec type IV variant. Eur J Clin Microbiol Infect Dis 29:9951002[CrossRef].[PubMed]
110. Mestas J, Polanco CM, Felsenstein S, Dien Bard J. 2014. Performance of the Verigene Gram-positive blood culture assay for direct detection of Gram-positive organisms and resistance markers in a pediatric hospital. J Clin Microbiol 52:283287[CrossRef].[PubMed]
111. Wojewoda CM, Sercia L, Navas M, Tuohy M, Wilson D, Hall GS, Procop GW, Richter SS. 2013. Evaluation of the Verigene Gram-positive blood culture nucleic acid test for rapid detection of bacteria and resistance determinants. J Clin Microbiol 51:20722076[CrossRef].[PubMed]
112. Peterson LR, Liesenfeld O, Woods CW, Allen SD, Pombo D, Patel PA, Mehta MS, Nicholson B, Fuller D, Onderdonk A. 2010. Multicenter evaluation of the LightCycler methicillin-resistant Staphylococcus aureus (MRSA) advanced test as a rapid method for detection of MRSA in nasal surveillance swabs. J Clin Microbiol 48:16611666[CrossRef].[PubMed]
113. Casalta JP, Gouriet F, Roux V, Thuny F, Habib G, Raoult D. 2009. Evaluation of the LightCycler SeptiFast test in the rapid etiologic diagnostic of infectious endocarditis. Eur J Clin Microbiol Infect Dis 28:569573[CrossRef].[PubMed]
114. Lehmann LE, Hauser S, Malinka T, Klaschik S, Weber SU, Schewe JC, Stüber F, Book M. 2011. Rapid qualitative urinary tract infection pathogen identification by SeptiFast real-time PCR. PLoS One 6:e17146[CrossRef].[PubMed]
115. Sancho-Tello S, Bravo D, Borrás R, Costa E, Muñoz-Cobo B, Navarro D. 2011. Performance of the LightCycler SeptiFast test Mgrade in detecting microbial pathogens in purulent fluids. J Clin Microbiol 49:29882991[CrossRef].[PubMed]
116. Sautter RL, Thomson RB Jr. 2015. Consolidated clinical microbiology laboratories. J Clin Microbiol 53:14671472[CrossRef].[PubMed]
117. Schroeder LF, Robilotti E, Peterson LR, Banaei N, Dowdy DW, Patel R. 2014. Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection. J Clin Microbiol 52:489496[CrossRef].[PubMed]
118. Lee TA, Hacek DM, Stroupe KT, Collins SM, Peterson LR. 2005. Three surveillance strategies for vancomycin-resistant enterococci in hospitalized patients: detection of colonization efficiency and a cost-effectiveness model. Infect Control Hosp Epidemiol 26:3946[CrossRef].[PubMed]
119. Huang SS, Septimus E, Avery TR, Lee GM, Hickok J, Weinstein RA, Moody J, Hayden MK, Perlin JB, Platt R, Ray GT. 2014. Cost savings of universal decolonization to prevent intensive care unit infection: implications of the REDUCE MRSA trial. Infect Control Hosp Epidemiol 35(Suppl 3):S23S31[CrossRef].[PubMed]
120. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R, CDC Prevention Epicenters Program, AHRQ DECIDE Network and Healthcare-Associated Infections Program. 2013. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 368:22552265[CrossRef].[PubMed]
121. de Forest N, Shukla S, Cox H, Ghavami B, Clute-Reining N, Chuc J, Scofield B, Dunphy K, Liu X, Rey D, Frei W. 2014. A novel transduction particle-based reporter assay enables a simple-to-use culture-free MRSA screening test. Abstract ID67. J Mol Diagnostics 16:742.

Tables

Generic image for table
TABLE 1

Commercial assays for MRSA/MSSA molecular testing

Citation: Mangold K, Peterson L. 2016. Molecular Detection of Colonization and Infection, p 169-184. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch15
Generic image for table
TABLE 2

Analytic performance of commercial assays for MRSA/MSSA molecular testing

Citation: Mangold K, Peterson L. 2016. Molecular Detection of Colonization and Infection, p 169-184. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch15
Generic image for table
TABLE 3

Laboratory workflow for commercial assays for MRSA/MSSA molecular testing

Citation: Mangold K, Peterson L. 2016. Molecular Detection of Colonization and Infection, p 169-184. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch15
Generic image for table
TABLE 4

Comparison of health care-associated infection outcome of universal decolonization ( ) with concurrent data from NorthShore University HealthSystem (authors' unpublished data)

Citation: Mangold K, Peterson L. 2016. Molecular Detection of Colonization and Infection, p 169-184. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch15

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error